M. Ghannoum

M. Ghannoum, C. Hager, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals

Patrick M. Gillevet, Mahmoud A. Ghannoum, Masoumeh Sikaroodi, 2010, PLoS pathogens.

Polymeric Nanofiber/Antifungal Formulations Using a Novel Co-extrusion Approach

G. Wnek, M. Ghannoum, E. Baer, 2017, AAPS PharmSciTech.

Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance

Mahmoud A. Ghannoum, Thomas McCormick, M. Ghannoum, 2001, Journal of bacteriology.

RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms.

Mahmoud A Ghannoum, M. Ghannoum, P. Mukherjee, 2004, Microbiology.

Voriconazole and Caspofungin Cidality Against Non-Albicans Candida Species

M. Ghannoum, N. Isham, 2007 .

High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group

M. Ghannoum, C. Shiboski, D. Dittmer, 2015, PloS one.

The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints.

M. Ghannoum, C. Shiboski, R. Jurevic, 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Antimicrobial Activity of Silver Containing Crosslinked Poly(Acrylic Acid) Fibers

S. Ahadian, G. Wnek, M. Ghannoum, 2019, Micromachines.

In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans

M. Ghannoum, R. Criddle, A. Ibrahim, 1995, Antimicrobial agents and chemotherapy.

The Role of Dectin-1 Signaling in Altering Tumor Immune Microenvironment in the Context of Aging

M. Ghannoum, P. Pandiyan, N. Bhaskaran, 2021, bioRxiv.

International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method

M. Ghannoum, J. Guarro, J. Turnidge, 2015, Antimicrobial Agents and Chemotherapy.

Correlative Changes of Growth, Pigmentation and Lipid Composition of Dunaliella salina in Response to Halostress

M. Ghannoum, S. Radwan, R. Al-Hasan, 1987 .

Potential role of phospholipases in virulence and fungal pathogenesis.

M. Ghannoum, 2000, Clinical microbiology reviews.

Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

M. Ghannoum, P. Mukherjee, J. Chandra, 2002, Antimicrobial Agents and Chemotherapy.

Human Beta-defensins: Differential Activity against Candidal Species and Regulation by Candida albicans

M. Ghannoum, J. Chandra, Zhimin Feng, 2005, Journal of dental research.

The Natural Diyne-Furan Fatty Acid EV-086 Is an Inhibitor of Fungal Delta-9 Fatty Acid Desaturation with Efficacy in a Model of Skin Dermatophytosis

R. Schneiter, M. Ghannoum, P. Roussel, 2013, Antimicrobial Agents and Chemotherapy.

Involvement of ADH1, IPT1 and PMT Genes in Candida albicans Pathogenesis

M. Ghannoum, M. Rouabhia, 2012 .

Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans

A. Casadevall, J. Perfect, M. Ghannoum, 2001, Molecular microbiology.

Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy

M. Ghannoum, P. Mukherjee, Sotohy A. Mohamed, 2004, Antimicrobial Agents and Chemotherapy.

Onychomycosis: diagnosis and definition of cure.

David G Armstrong, Roderick J Hay, Mahmoud Ghannoum, 2007, Journal of the American Academy of Dermatology.

Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active‐controlled study and in vitro assays

M. Ghannoum, N. Kerrouche, B. Sigurgeirsson, 2016, Mycoses.

A second look at efficacy criteria for onychomycosis: clinical and mycological cure

M. Ghannoum, N. Isham, V. Catalano, 2014, The British journal of dermatology.

Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild‐to‐moderate toenail onychomycosis: results from three randomized studies using double‐blind vehicle‐controlled and open‐label active‐controlled designs

B. Elewski, M. Ghannoum, B. Damaj, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Studies on the anticandidal mode of action of Allium sativum (garlic).

M. Ghannoum, 1988, Journal of general microbiology.

GM-CSF: Orchestrating the Pulmonary Response to Infection

M. Ghannoum, T. McCormick, R. Hejal, 2022, Frontiers in Pharmacology.

Potential Role of Phospholipases in Virulence and Fungal Pathogenesis

M. Ghannoum, 2000, Clinical Microbiology Reviews.

Ghannoum Virulence and Fungal Pathogenesis Potential Role of Phospholipases in

M. Ghannoum, 1999 .

Extracellular phospholipases as universal virulence factor in pathogenic fungi.

M. Ghannoum, 1998, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro

M. Ghannoum, M. Selsted, A. Ibrahim, 1993, Antimicrobial Agents and Chemotherapy.

Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales

M. Ghannoum, J. Guarro, J. Turnidge, 2015, Antimicrobial Agents and Chemotherapy.

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

M. Ghannoum, M. Castanheira, S. Lockhart, 2012, Journal of Clinical Microbiology.

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

M. Ghannoum, J. Turnidge, T. Peláez, 2011, Antimicrobial Agents and Chemotherapy.

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods

M. Ghannoum, B. Alexander, J. Rex, 2009, Journal of Clinical Microbiology.

Reduced virulence of Candida albicans PHR1 mutants

M. Ghannoum, B. Spellberg, W. Fonzi, 1995, Infection and immunity.

Attributes of Stachybotrys chartarum and its association with human disease.

M. Ghannoum, M. A. Hossain, Mohamed S. Ahmed, 2004, The Journal of allergy and clinical immunology.

Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: Improved understanding and new strategic approach with sargramostim

M. Ghannoum, H. Lazarus, T. McCormick, 2021, Clinical Immunology.

Distinct Roles for Dectin-1 and TLR4 in the Pathogenesis of Aspergillus fumigatus Keratitis

M. Ghannoum, S. Leal, E. Pearlman, 2010, PLoS pathogens.

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

P. Nyirjesy, M. Ghannoum, R. Sobel, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Inhibition of Monocytic Interleukin-12 Production by Candida albicans via Selective Activation of ERK Mitogen-Activated Protein Kinase

M. Ghannoum, P. Mukherjee, M. Takahara, 2004, Infection and Immunity.

Central Venous Catheter–associated Nocardia Bacteremia in Cancer Patients

M. Ghannoum, D. Kontoyiannis, J. Tarrand, 2011, Emerging infectious diseases.

In Vitro and In Vivo Activity of a Novel Catheter Lock Solution against Bacterial and Fungal Biofilms

M. Ghannoum, K. Appelt, P. Mukherjee, 2018, Antimicrobial Agents and Chemotherapy.

CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms

M. Ghannoum, J. Chandra, 2017, Antimicrobial Agents and Chemotherapy.

Candida biofilms associated with CVC and medical devices

M. Ghannoum, P. Mukherjee, J. Chandra, 2012 .

In vitro growth and analysis of Candida biofilms

M. Ghannoum, P. Mukherjee, J. Chandra, 2008, Nature Protocols.

Cutaneous hypersensitivity to Malassezia sympodialis and dust mite in adult atopic dermatitis with a textile pattern

M. Schluchter, M. Ghannoum, T. McCormick, 2006, Contact dermatitis.

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease

S. Vermeire, M. Ghannoum, P. Mukherjee, 2016, mBio.

Disruption of sphingolipid biosynthetic gene IPT1 reduces Candida albicans adhesion and prevents activation of human gingival epithelial cell innate immune defense.

M. Ghannoum, P. Mukherjee, M. Rouabhia, 2010, Medical mycology.

High-temperature hydrocarbon degradation by Bacillus stearothermophilus from oil-polluted Kuwaiti desert

M. Ghannoum, S. Radwan, A. Ibrahim, 1993, Applied Microbiology and Biotechnology.

A Novel Actin Binding Drug with In Vivo Efficacy

S. W. Lockless, M. Ghannoum, Leif Smith, 2018, Antimicrobial Agents and Chemotherapy.

Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.

M. Ghannoum, P. Mukherjee, L. Long, 2009, International journal of antimicrobial agents.

Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.

M. Ghannoum, P. Mukherjee, P. Mukherjee, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans.

M. Ghannoum, P. Mukherjee, G. Reyes, 2003, The Journal of antimicrobial chemotherapy.

The Probiotic BIOHM Improves Nutrient Absorption by Disrupting Gastrointestinal Biofilms

M. Ghannoum, M. Retuerto, T. McCormick, 2019 .

Indole-3-acetic acid synthesized through the indole-3-pyruvate pathway promotes Candida tropicalis biofilm formation

Keiko Umeda, M. Ghannoum, M. Miyagi, 2020, PloS one.

Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology

A. Grada, M. Ghannoum, C. Bunick, 2022, Antibiotics.

The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)

M. Ghannoum, S. Asa, N. Avril, 2022, Current issues in molecular biology.

Mycobiota in gastrointestinal diseases

M. Ghannoum, P. Mukherjee, J. Colombel, 2015, Nature Reviews Gastroenterology &Hepatology.

Nature Reviews UNCORRECTED PROOF

M. Ghannoum, P. Mukherjee, J. Colombel, 2014 .

Host Defense at the Ocular Surface

M. Ghannoum, E. Pearlman, L. Szczotka-Flynn, 2013, International reviews of immunology.

Cloning and Characterization of CAD 1 / AAF 1 , a Gene from Candida albicans That Induces Adherence to Endothelial Cells after Expression in Saccharomyces cerevisiae

M. Ghannoum, T. Kanbe, S. Filler, 1998 .

Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro

M. Ghannoum, P. Mukherjee, J. Chandra, 2001, Journal of dental research.

Animal models to investigate fungal biofilm formation.

M. Ghannoum, E. Pearlman, J. Chandra, 2014, Methods in molecular biology.

Dimorphism-associated variations in the lipid composition of Candida albicans.

M. Ghannoum, S. Radwan, G. Janini, 1986, Journal of general microbiology.

Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans.

M. Ghannoum, S. Nakashima, Y. Nozawa, 1999, Medical mycology.

Recombinant human granulocyte macrophage-colony stimulating factor expressed in yeast (sargramostim): A potential ally to combat serious infections.

M. Ghannoum, T. McCormick, G. Damiani, 2020, Clinical immunology.

Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans.

M. Ghannoum, A. Ibrahim, W. Fonzi, 1997, Microbiology.

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections

M. Ghannoum, E. Berkow, B. Tarai, 2020, Antibiotics.

Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus

M. Ghannoum, J. Meis, S. Arikan‐Akdagli, 2018, Journal of fungi.

Modification of Surface Properties of Biomaterials Influences the Ability of Candida albicans To Form Biofilms

M. Ghannoum, James M. Anderson, Jian Li, 2005, Applied and Environmental Microbiology.

Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicans.

A. Beauvais, J. Latgé, M. Ghannoum, 1998, Medical mycology.

Fusarium and Candida albicans Biofilms on Soft Contact Lenses: Model Development, Influence of Lens Type, and Susceptibility to Lens Care Solutions

M. Ghannoum, P. Mukherjee, K. O’Donnell, 2007, Antimicrobial Agents and Chemotherapy.

Molecular cloning of a gene encoding translation initiation factor (TIF) from Candida albicans.

M. Ghannoum, S. Nakashima, Y. Nozawa, 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro

M. Ghannoum, A. Ibrahim, A. Bayer, 1993, Antimicrobial Agents and Chemotherapy.

Interferon-γ Protects Endothelial Cells from Damage by Candida albicans

M. Ghannoum, S. Filler, A. Ibrahim, 1993 .

Experimental animal models of invasive fungal infections

M. Ghannoum, Y. Imamura, C. Hager, 2016, Antifungal Therapy.

Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light

M. Ghannoum, C. Donskey, J. Cadnum, 2017, Infection Control & Hospital Epidemiology.

The incidence of water-related diseases in the Brak area, Libya from 1977 to 1979, before and after the installation of water treatment plants.

K. E. Moore, M. Ghannoum, M. Al-Dulaimi, 1981, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale B, Hygiene.

Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.

M. Ghannoum, P. Mukherjee, E. Pearlman, 2012, Investigative ophthalmology & visual science.

A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates

M. Ghannoum, K. Borroto-Esoda, T. McCormick, 2020, Antimicrobial Agents and Chemotherapy.

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

M. Ghannoum, P. Mukherjee, D. Andes, 2018, Antimicrobial Agents and Chemotherapy.

Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy.

J. Perfect, M. Ghannoum, J. Gallant, 1999, AIDS research and human retroviruses.

Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program

M. Ghannoum, V. Lavergne, K. Weiss, 2011, Bone Marrow Transplantation.

Subinhibitory concentration of octenidine and pirtenidine: influence on the lipid and sterol contents of Candida albicans.

M. Ghannoum, P. Whittaker, N. M. Moussa, 1992, Chemotherapy.

Lanosterol and diacylglycerophosphocholines in lipids from whole cells and thylakoids of the cyanobacterium Chlorogloeopsis fritschii

M. Ghannoum, S. Radwan, N. Nimer, 1987, Archives of Microbiology.

A Novel Transdermal Application for Clearing Skin Colonization by Candida auris

M. Ghannoum, T. McCormick, L. Long, 2021, Antimicrobial Agents and Chemotherapy.

Cloning and characterization of a gene ( LIPI ) which encodes a lipase from the pathogenic yeast Candida albicans

M. Ghannoum, W. Fonzi, Yue Fu, 2008 .

Activity of a Novel 1,3-Beta-d-Glucan Synthase Inhibitor, Ibrexafungerp (Formerly SCY-078), against Candida glabrata

M. Ghannoum, K. Borroto-Esoda, N. Isham, 2019, Antimicrobial Agents and Chemotherapy.

SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies

M. Ghannoum, K. Borroto-Esoda, M. Peel, 2017, Antimicrobial Agents and Chemotherapy.

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

M. Ghannoum, B. Alexander, Steven D. Brown, 2008, Journal of Clinical Microbiology.

Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy

M. Ghannoum, G. Socié, P. Ribaud, 2008, Haematologica.

Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against Influenza Viruses in vitro and in vivo

Daniel L. Popkin, M. Ghannoum, P. Mukherjee, 2017, Pathogens & immunity.

Fungal Biofilms in the Clinical Lab Setting

M. Ghannoum, P. Mukherjee, J. Chandra, 2010 .

Blocking Adherence of Candida albicans to Buccal Epithelial Cells by Yeast Glycolipids, Yeast Wall Lipids and Lipids from Epithelial Cells./Adhärenzhemmung von Candida albicans an Mundschleimhaut‐Epithelzellen durch Hefe‐Glykolipide, Hefezellwand‐Lipide und Epithelzell‐Lipide

M. Ghannoum, S. Radwan, K. Abu El‐Teen, 1987, Mykosen.

Biofilms and beyond: expanding echinocandin utility.

M. Ghannoum, E. Larkin, S. Dharmaiah, 2018, The Journal of antimicrobial chemotherapy.

Flucytosine Treatment and Resistance Mechanisms

M. Ghannoum, J. Chandra, 2017 .

Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections.

M. Ghannoum, F. Muakkassa, 2016, Advances in experimental medicine and biology.

The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.

M. Ghannoum, T. Walsh, A. Katragkou, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients

M. Ghannoum, H. Lazarus, H. Lazarus, 2004, Bone Marrow Transplantation.

FOCUS Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

M. Ghannoum, J. Rex, T. Walsh, 2001 .

Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status

M. Ghannoum, C. Shiboski, D. Dittmer, 2017, AIDS.

Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models

M. Ghannoum, H. Sanati, C. Ramos, 1997, Antimicrobial agents and chemotherapy.

Quorum-Sensing Dysbiotic Shifts in the HIV-Infected Oral Metabiome

M. Ghannoum, P. Mukherjee, P. Gillevet, 2015, PloS one.

Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis

M. Ghannoum, K. Borroto-Esoda, N. Isham, 2018, Antimicrobial Agents and Chemotherapy.

Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation

M. Ghannoum, T. Walsh, M. Pfaller, 2001, Antimicrobial Agents and Chemotherapy.

Fungal biofilms and catheter-associated infections

M. Ghannoum, J. Chandra, 2009, Antifungal Therapy.

Is antifungal susceptibility testing useful in guiding fluconazole therapy?

M. Ghannoum, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis

M. Ghannoum, S. Filler, A. Bayer, 1996, Infection and immunity.

Parenteral lipid emulsion induces germination of Candida albicans and increases biofilm formation on medical catheter surfaces.

M. Ghannoum, P. Mukherjee, J. Chandra, 2009, The Journal of infectious diseases.

Resistance of Candida to azoles and echinocandins worldwide.

M. Ghannoum, K. E. Pristov, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A rabbit model for evaluation of catheter-associated fungal biofilms

M. Ghannoum, P. Mukherjee, J. Chandra, 2011, Virulence.

Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor

M. Ghannoum, P. Mukherjee, Mingyue Wang, 2008, BMC Microbiology.

Anidulafungin: A Potent Antifungal that Targets Candida and Aspergillus

M. Ghannoum, M. D'Angelo, 2005 .

Infectious Diseases of the Skin I: Dermatophytosis/Onychomycosis

M. Ghannoum, P. Mukherjee, N. Isham, 2011 .

Zygomycosis: the re-emerging fungal infection

J. Perfect, M. Ghannoum, M. Chayakulkeeree, 2006, European Journal of Clinical Microbiology and Infectious Diseases.

Pathogenesis of Fungal Keratitis

M. Ghannoum, P. Mukherjee, S. Leal, 2010 .

Hyphae and Yeasts of Candida albicans Differentially Regulate Interleukin-12 Production by Human Blood Monocytes: Inhibitory Role of C. albicans Germination

M. Ghannoum, M. Takahara, Liming Liu, 2001, Infection and Immunity.

Update on the Pathogenesis, Virulence, and Treatment of Candida auris

M. Ghannoum, R. Watkins, M. Lionakis, 2022, Pathogens & immunity.

Fungicidal Properties ofDefensin NP-1andActivity against Cryptococcus neoformans InVitro

M. Ghannoum, M. Selsted, A. Ibrahim, 1993 .

Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection

M. Ghannoum, R. Sékaly, M. Retuerto, 2022, The Journal of clinical investigation.

Mechanisms of fungal resistance: an overview.

M. Ghannoum, P. Mukherjee, S. Leidich, 2002, Drugs.

Fluconazole Susceptibility Testing of Cryptococcus neoformans: Comparison of Two Broth Microdilution Methods and Clinical Correlates among Isolates from Ugandan AIDS Patients

M. Ghannoum, M. Pfaller, S. Messer, 1998, Journal of Clinical Microbiology.

MyD88 Regulation of Fusarium Keratitis Is Dependent on TLR4 and IL-1R1 but Not TLR21

M. Ghannoum, P. Mukherjee, E. Pearlman, 2008, The Journal of Immunology.

The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo

M. Ghannoum, B. Fuchs, E. Mylonakis, 2020, Scientific Reports.

An evaluation of the in vitro activity of terbinafine.

M. Ghannoum, C. Jessup, N. Ryder, 2000, Medical mycology.

Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

M. Ghannoum, Steven D. Brown, J. Rex, 2000, Journal of Clinical Microbiology.

Candida biofilms: antifungal resistance and emerging therapeutic options.

M. Ghannoum, D. Kuhn, 2004, Current opinion in investigational drugs.

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

M. Ghannoum, J. Galgiani, J. Rex, 1996, Journal of clinical microbiology.

Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule

M. Ghannoum, T. Kozel, S. Filler, 1995, Infection and immunity.

Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation.

M. Ghannoum, P. Mukherjee, R. Welti, 2011, Microbiology.

Cutaneous dysbiosis may amplify barrier dysfunction in patients with atopic dermatitis

M. Ghannoum, P. Mukherjee, T. McCormick, 2022, Frontiers in Microbiology.

New developments in chemotherapy for non-invasive fungal infections

M. Ghannoum, M. A. Hossain, M. A. Hossain, 2001, Expert opinion on investigational drugs.

Reduced Virulence ofCandida albicans PHR1Mutants

M. Ghannoum, B. Spellberg, S. Saporito-irwin, 1995 .

Effects of a Novel Probiotic Combination on Pathogenic Bacterial-Fungal Polymicrobial Biofilms

M. Ghannoum, M. Miyagi, J. Chandra, 2019, mBio.

Ability of Hydroxypropyl Chitosan Nail Lacquer To Protect against Dermatophyte Nail Infection

M. Ghannoum, M. Caserini, F. Mailland, 2014, Antimicrobial Agents and Chemotherapy.

Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis

M. Ghannoum, S. Filler, J. Edwards, 1996, Infection and immunity.

Echinocandins: Are They All The Same?

M. Ghannoum, P. Mukherjee, P. Mukherjee, 2011, Journal of chemotherapy.

Mechanisms by which Candida albicans induces endothelial cell prostaglandin synthesis

M. Ghannoum, S. Filler, J. Raj, 1994, Infection and immunity.

Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model

M. Ghannoum, C. Hager, L. Long, 2018, The Journal of antimicrobial chemotherapy.

In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris

M. Ghannoum, K. Shaw, C. Hager, 2018, Antimicrobial Agents and Chemotherapy.

VT-1161 Dosed Once Daily or Once Weekly Exhibits Potent Efficacy in Treatment of Dermatophytosis in a Guinea Pig Model

M. Ghannoum, E. Garvey, R. Schotzinger, 2015, Antimicrobial Agents and Chemotherapy.

Susceptibility testing of Cryptococcus neoformans: a microdilution technique

M. Ghannoum, R. Criddle, A. Ibrahim, 1992, Journal of clinical microbiology.

Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model.

M. Ghannoum, L. Long, P. Mallefet, 2010, Medical mycology.

Effi cacy of terbinafi ne compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model

M. Ghannoum, L. Long, P. Mallefet, 2010 .

Adherence of Candida albicans: Influencing Factors and Mechanism(s)

M. Ghannoum, K. Abu-Elteen, 1991 .

Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models

M. Ghannoum, J. Rex, T. Walsh, 1998, Antimicrobial Agents and Chemotherapy.

Antifungal hydrogels

Robert Langer, Gerald R. Fink, Daniel S. Kohane, 2007, Proceedings of the National Academy of Sciences.

Evaluate the Ability of CD 101 to Prevent and Treat Candida albicans Biofilms and Explore its Temporal Effect by Time Lapse Photography

M. Ghannoum, J. Chandra, T. Sandison, 2017 .

In vitro effect of over-the-counter probiotics on the ability of Candida albicans to form biofilm on denture strips.

M. Ghannoum, P. Mukherjee, T. Thakre, 2014, Journal of dental hygiene : JDH.

Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms.

M. Ghannoum, P. Mukherjee, J. Chandra, 2012, The Journal of antimicrobial chemotherapy.

Gentian Violet Exhibits Activity against Biofilms Formed by Oral Candida Isolates Obtained from HIV-Infected Patients

M. Ghannoum, P. Mukherjee, R. Jurevic, 2011, Antimicrobial Agents and Chemotherapy.

Gentian Violet Exhibits Activity against Bioﬁlms Formed by Oral Candida Isolates Obtained from HIV-Infected Patients (cid:1)

M. Ghannoum, P. Mukherjee, R. Jurevic, 2011 .

Gentian Violet Exhibits Activity against Biofilms formed by 2 Oral Candida isolates Obtained from HIV-infected Patients 3 4 Running title : Anti-biofilm activity of gentian violet 5

M. Ghannoum, P. Mukherjee, R. Jurevic, 2011 .

Oral Candida isolates Obtained from HIV-infected Patients

M. Ghannoum, P. Mukherjee, R. Jurevic, 2011 .

Voriconazole -- better chances for patients with invasive mycoses.

M. Ghannoum, D. Kuhn, 2002, European journal of medical research.

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.

M. Ghannoum, B. Alexander, Steven D. Brown, 2011, Diagnostic microbiology and infectious disease.

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora

M. Ghannoum, J. Galgiani, J. Rex, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Microbial Contamination of Contact Lenses, Lens Care Solutions, and Their Accessories: A Literature Review

Mahmoud Ghannoum, M. Ghannoum, E. Pearlman, 2010, Eye & contact lens.

Oral Mycobiome Analysis of HIV-Infected Patients: Identification of Pichia as an Antagonist of Opportunistic Fungi

Patrick M. Gillevet, Michael M. Lederman, Mahmoud A. Ghannoum, 2014, PLoS pathogens.

Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A Reference Method for Testing Clinical Isolates of Common and Emerging Candidaspp., Cryptococcus spp., and Other Yeasts and Yeast-Like Organisms

M. Ghannoum, M. Pfaller, S. Messer, 1999, Journal of Clinical Microbiology.

Evidence implicating phospholipase as a virulence factor of Candida albicans

M. Ghannoum, Y. Banno, Y. Nozawa, 1995, Infection and immunity.

Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo.

M. Ghannoum, P. Mukherjee, J. Chandra, 2001, Microbiology.

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

M. Ghannoum, J. Rex, T. Walsh, 2001, Clinical Microbiology Reviews.

Effects of the pyridinamines octenidine and pirtenidine on yeast mitochondrial function.

M. Ghannoum, P. Whittaker, Mohamed Suliman Ellabib, 1990, Biochemical Society transactions.

Candida albicans antifungal‐resistant strains: studies on adherence and other pathogenicity related characteristics

M. Ghannoum, M. Ghannoum, 1992, Mycoses.

Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells

M. Ghannoum, S. Radwan, G. Burns, 1986, Infection and immunity.

Indoor Mold, Toxigenic Fungi, and Stachybotrys chartarum: Infectious Disease Perspective

M. Ghannoum, D. Kuhn, D. M. Kuhn, 2003, Clinical Microbiology Reviews.

New investigational antifungal agents for treating invasive fungal infections

M. Ghannoum, M. A. Hossain, 2000, Expert opinion on investigational drugs.

Antimicrobial activity of some 2-aminopyrimidines.

M. Ghannoum, N. El-Rayyes, K. Abu Elteen, 1989, Microbios.

Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine

M. Ghannoum, P. Mukherjee, N. Ryder, 2003, Antimicrobial Agents and Chemotherapy.

Mode of action of the antimicrobial compound 5-Bromo-5-nitro-1,3-dioxane (Bronidox)

M. Ghannoum, W. Bowman, S. Al-khalil, 2008, Folia Microbiologica.

Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method

M. Ghannoum, B. Alexander, Steven D. Brown, 2008, Antimicrobial Agents and Chemotherapy.

Quality Control and Reference Guidelines for CLSI Broth Microdilution Susceptibility Method (M38-A Document) for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole

M. Ghannoum, W. Schell, T. Walsh, 2005, Journal of Clinical Microbiology.

The Exciting Future of Antifungal Therapy

M. Ghannoum, M. Neely, Mahmoud A. Ghannoum, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Future of antimycotic therapy

M. Ghannoum, 1997 .

Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action.

M. Ghannoum, 2015, Journal of the American Podiatric Medical Association.

Novel Antiseptic Urinary Catheters for Prevention of Urinary Tract Infections: Correlation of In Vivo and In Vitro Test Results

Ying Jiang, Rajesh Uthamanthil, Peggy Tinkey, 2009, Antimicrobial Agents and Chemotherapy.

Susceptibility testing of fungi and correlation with clinical outcome.

M. Ghannoum, 1997, Journal of chemotherapy.

Crude oil and hydrocarbon-degrading strains of Rhodococcus rhodochrous isolated from soil and marine environments in Kuwait.

M. Ghannoum, S. Radwan, A. Ibrahim, 1990, Environmental pollution.

Comparison between the Standardized Clinical and Laboratory Standards Institute M38-A2 Method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-Tetrazolium Hydroxide- Based Method for Testing Antifungal Susceptibility of Dermatophytes

M. Ghannoum, P. Mukherjee, A. Shehata, 2008, Journal of Clinical Microbiology.

Methods for Testing Antifungal Susceptibility of Dermatophytes

M. Ghannoum, P. Mukherjee, A. Shehata, 2008 .

CHAPTER 16 – Dermatophytes and dermatophytoses

M. Ghannoum, N. Isham, 2009 .

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

M. Ghannoum, K. Borroto-Esoda, T. McCormick, 2021, Frontiers in Cellular and Infection Microbiology.

Tinea capitis in Cleveland: survey of elementary school students.

B. Elewski, M. Ghannoum, R. Hajjeh, 2003, Journal of the American Academy of Dermatology.

Antifungal Susceptibility Testing of Dermatophytes: Establishing a Medium for Inducing Conidial Growth and Evaluation of Susceptibility of Clinical Isolates

M. Ghannoum, C. Jessup, N. Isham, 2000, Journal of Clinical Microbiology.

Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces

M. Ghannoum, P. Mukherjee, P. Mukherjee, 2002, Infection and Immunity.

A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.

B. Elewski, M. Ghannoum, S. Friedlander, 2005, Journal of the American Academy of Dermatology.

Interlaboratory Study of Quality Control Isolates for a Broth Microdilution Method (Modified CLSI M38-A) for Testing Susceptibilities of Dermatophytes to Antifungals

M. Ghannoum, T. Walsh, M. Pfaller, 2006, Journal of Clinical Microbiology.

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens

M. Ghannoum, M. Shoham, W. Harte, 2018, Scientific Reports.

Evaluation of C. albicans Adhesion and Growthon Restorative Dental Materials Enriched or not with Fluoride

M. Ghannoum, Adil Akkouch, M. Rouabhia, 2012 .

Cloning and Disruption of caPLB1, a Phospholipase B Gene Involved in the Pathogenicity of Candida albicans *

M. Ghannoum, S. Nakashima, Y. Nozawa, 1998, The Journal of Biological Chemistry.

Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002.

B. Elewski, M. Ghannoum, K. W. Foster, 2004, Journal of the American Academy of Dermatology.

The role of nondermatophyte molds in onychomycosis: diagnosis and treatment

M. Ghannoum, M. V. Vander Straten, M. Balkis, 2002 .

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.

B. Elewski, M. Ghannoum, R. Summerbell, 2000, Journal of the American Academy of Dermatology.

Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method.

M. Ghannoum, H. Norris, B. Elewski, 1999, Journal of the American Academy of Dermatology.

Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes

M. Ghannoum, H. Yamaguchi, N. Isham, 2009, Mycoses.

Therapeutic potential of TDT 067 (terbinafine in Transfersome®): a carrier-based dosage form of terbinafine for onychomycosis

M. Ghannoum, B. Sigurgeirsson, 2012, Expert opinion on investigational drugs.

Activity of TDT 067 (Terbinafine in Transfersome) against Agents of Onychomycosis, as Determined by Minimum Inhibitory and Fungicidal Concentrations

M. Ghannoum, N. Isham, W. Henry, 2011, Journal of Clinical Microbiology.

In vitro activity of CAY-1, a saponin from Capsicum frutescens, against Microsporum and Trichophyton species.

M. Ghannoum, T. Walsh, S. Boue, 2008, Medical Mycology.

Single-Step PCR Using (GACA)4 Primer: Utility for Rapid Identification of Dermatophyte Species and Strains

M. Ghannoum, P. Mukherjee, S. Abbadi, 2008, Journal of Clinical Microbiology.

Intra- and Interlaboratory Study of a Method for Testing the Antifungal Susceptibilities of Dermatophytes

M. Ghannoum, M. Pfaller, M. Rinaldi, 2004, Journal of Clinical Microbiology.

Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates.

M. Ghannoum, N. Ryder, B. Favre, 2004, Medical mycology.

689 Efficacy of CD101, a novel echinocandin, in the treatment of dermatophytosis using a Guinea Pig (GP) Model

M. Ghannoum, C. Hager, L. Long, 2017 .

Treatment-resistant dermatophytosis: A representative case highlighting an emerging public health threat

B. Elewski, M. Ghannoum, M. Hatch, 2020, JAAD case reports.

Voriconazole Susceptibilities of Dermatophyte Isolates Obtained from a Worldwide Tinea Capitis Clinical Trial

M. Ghannoum, D. Sheehan, N. Isham, 2006, Journal of Clinical Microbiology.

Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial

M. Ghannoum, J. Nyirady, N. Isham, 2008, The British journal of dermatology.

Treatment‐resistant tinea corporis, a potential public health issue

M. Ghannoum, E. Chen, B. Elewski, 2020, The British journal of dermatology.

Epidemiology of Onychomycosis

M. Ghannoum, I. Salem, L. Christensen, 2018 .

Molecular analysis of dermatophytes suggests spread of infection among household members.

E. Warshaw, M. Ghannoum, S. Evans, 2013, Cutis.

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

M. Ghannoum, R. Rubin, J. Solomkin, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reactivity to trichophytin antigen in patients with onychomycosis: effect of terbinafine.

B. Elewski, M. Ghannoum, K. Cooper, 2002, Journal of the American Academy of Dermatology.

Examining the importance of laboratory and diagnostic testing when treating and diagnosing onychomycosis

M. Ghannoum, P. Mukherjee, N. Isham, 2018, International journal of dermatology.

Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard

M. Ghannoum, B. Alexander, S. Lockhart, 2017, Journal of Clinical Microbiology.

Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111

M. Ghannoum, T. Walsh, R. Rennie, 2015, Journal of Clinical Microbiology.

Agar-Based Disk Diffusion Assay for Susceptibility Testing of Dermatophytes

M. Ghannoum, P. Mukherjee, E. Nweze, 2010, Journal of Clinical Microbiology.

Susceptibility testing of dermatophytes

M. Ghannoum, N. Isham, David V. Chand, 2009 .

Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail

M. Ghannoum, M. Bradley, N. Isham, 1999, Mycoses.

Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.

B. Elewski, M. Ghannoum, N. Isham, 1999, Mycoses.

Evaluation of the Ability of a Novel Miconazole Formulation To Penetrate Nail by Using Three In Vitro Nail Models

M. Ghannoum, Marc B. Brown, F. Caserta, 2017, Antimicrobial Agents and Chemotherapy.

Examining the Benefits of the Boron-Based Mechanism of Action and Physicochemical Properties of Tavaborole in the Treatment of Onychomycosis.

M. Ghannoum, Aditya K. Gupta, F. Rock, 2018, Journal of the American Podiatric Medical Association.

Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model

M. Ghannoum, L. Long, W. Pfister, 2009, Mycoses.

Diagnosing Onychomycosis: What’s New?

M. Ghannoum, E. Cooper, Aditya K Gupta, 2022, Journal of fungi.

Fungal Nail Infections (Onychomycosis): A Never-Ending Story?

M. Ghannoum, N. Isham, 2014, PLoS pathogens.

Human Hyalohyphomycoses: A Review of Human Infections Due to Acremonium spp., Paecilomyces spp., Penicillium spp., and Scopulariopsis spp.

M. Ghannoum, M. Schinabeck, M. Ghannoum, 2003, Journal of chemotherapy.

New targets and delivery systems for antifungal therapy.

M. Ghannoum, T. Walsh, A. Groll, 2000, Medical mycology.

In Vitro Antifungal Activity of ME1111, a New Topical Agent for Onychomycosis, against Clinical Isolates of Dermatophytes

M. Ghannoum, N. Isham, L. Long, 2015, Antimicrobial Agents and Chemotherapy.

Clinical Effects of Gamma-Radiation-Resistant Aspergillus sydowii on Germ-Free Mice Immunologically Prone to Inflammatory Bowel Disease

M. Ghannoum, M. Retuerto, F. Cominelli, 2016, Journal of pathogens.

A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails

M. Ghannoum, L. Long, Gernot Kunze, 2019, Mycoses.

Potentiation of Azole Antifungals by 2-Adamantanamine

M. Ghannoum, T. Dahl, A. Nantel, 2013, Antimicrobial Agents and Chemotherapy.

Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth

M. Ghannoum, R. Criddle, A. Ibrahim, 1989, Antimicrobial Agents and Chemotherapy.

A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei

M. Ghannoum, H. Sanati, R. Fratti, 1997, Antimicrobial agents and chemotherapy.

Antifungal activity of miconazole against recent Candida strains

M. Ghannoum, N. Isham, 2010, Mycoses.

Flucytosine: Site of Action, Mechanism of Resistance and Use in Combination Therapy

M. Ghannoum, J. Chandra, S. Mohammad, 2009 .

Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole

M. Ghannoum, M. Witt, M. Pfaller, 1996, Journal of clinical microbiology.

Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.

R. Haubrich, M. Ghannoum, R. Lewis, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device.

M. Ghannoum, N. Isham, L. Long, 2012, Journal of the American Podiatric Medical Association.

Evaluation of the Efficacy of ME1111 in the Topical Treatment of Dermatophytosis in a Guinea Pig Model

M. Ghannoum, C. Hager, L. Long, 2016, Antimicrobial Agents and Chemotherapy.

Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species

M. Ghannoum, C. Nast, H. Sanati, 1997, Antimicrobial agents and chemotherapy.

Antimycotic effects of octenidine and pirtenidine.

M. Ghannoum, P. Whittaker, Mohamed Suliman Ellabib, 1990, The Journal of antimicrobial chemotherapy.

Combination Treatment of Invasive Fungal Infections

M. Ghannoum, P. Mukherjee, D. Sheehan, 2005, Clinical Microbiology Reviews.

Efficacy of NVC‐422 in the treatment of dermatophytosis caused by Trichophyton mentagrophytes using a guinea pig model

M. Ghannoum, Ron Najafi, L. Long, 2013, International journal of dermatology.

Evaluation of Antifungal Efficacy in an Optimized Animal Model of Trichophyton mentagrophytes-Dermatophytosis

M. Ghannoum, P. Mukherjee, M. A. Hossain, 2004, Journal of chemotherapy.

Evaluation of the Morphological Effects of TDT 067 (Terbinafine in Transfersome) and Conventional Terbinafine on Dermatophyte Hyphae In Vitro and In Vivo

M. Ghannoum, N. Isham, W. Henry, 2012, Antimicrobial Agents and Chemotherapy.

Amorolfine 5% Nail Lacquer Exhibits Potent Antifungal Activity Compared to Three Acid-Based Devices Indicated for the Treatment of Onychomycosis: An In Vitro Nail Penetration Assay

M. Ghannoum, M. Sarkany, K. Sevin, 2016, Dermatologic Therapy.

Interactive effects of antifungal and antineoplastic agents on yeasts commonly prevalent in cancer patients

M. Ghannoum, R. Criddle, M. Motawy, 1989, Antimicrobial Agents and Chemotherapy.

Effects of Fluconazole Singly and in Combination with 5-Fluorocytosine or Amphotericin B in the Treatment of Cryptococcal Meningoencephalitis in an Intracranial Murine Model

M. Ghannoum, M. A. Hossain, L. Long, 2002, Journal of chemotherapy.

species.eptible and -resistant Candida and alters the morphology of Voriconazole (UK-109,496) inhibits the growth

M. Ghannoum, C. Nast, H. Sanati, 2013 .

Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants

K. Freedberg, M. Ghannoum, C. Shiboski, 2017, AIDS.

Yeast susceptibility testing: reference methods and commercial test systems

M. Ghannoum, 2001 .

A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis

P. Nyirjesy, M. Ghannoum, J. Sobel, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of Antineoplastic Agents on the Growth and Ultrastructure of Candida Albicans

M. Ghannoum, M. Ghannoum, A. Al-Khars, 1984, Mykosen.

Candida: a causative agent of an emerging infection.

M. Ghannoum, M A Ghannoum, 2001, The journal of investigative dermatology. Symposium proceedings.

Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols

M. Ghannoum, P. Mukherjee, J. Chandra, 2003, Infection and Immunity.

Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans.

M. Ghannoum, K. Abu Elteen, 1986, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.

M. Ghannoum, M. Pfaller, D. Diekema, 2012, Diagnostic microbiology and infectious disease.

Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Panel for Antifungal Susceptibility Testing of the Echinocandins Anidulafungin, Caspofungin, and Micafungin

M. Ghannoum, M. Pfaller, D. Diekema, 2008, Journal of Clinical Microbiology.

Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel.

M. Ghannoum, M. Pfaller, S. Messer, 1998, Diagnostic microbiology and infectious disease.

Effectiveness of Disinfectants Against Candida auris and Other Candida Species

M. Ghannoum, C. Donskey, J. Cadnum, 2017, Infection Control & Hospital Epidemiology.

The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.

M. Ghannoum, H. Sanati, R. Fratti, 1998, Journal of chemotherapy.

Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B

M. Ghannoum, S. Filler, A. Ibrahim, 1992, Antimicrobial Agents and Chemotherapy.

Mechanisms of Fungal Resistance

M. Ghannoum, P. Mukherjee, S. Leidich, 2012, Drugs.

Clinically Promising New Triazoles for Systemic Fungal Infections

M. Ghannoum, M. Neely, D. Sheehan, 2004 .

Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole

M. Ghannoum, E. Sionov, K. Kwon-Chung, 2011, Antimicrobial Agents and Chemotherapy.

In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.

M. Ghannoum, Jinchao Zhang, M. Brandt, 1999, Antimicrobial agents and chemotherapy.

Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.

M. Ghannoum, L. Long, H. G. Kim, 2007, The Journal of antimicrobial chemotherapy.

Emerging Issues in Antifungal Resistance.

J. Perfect, M. Ghannoum, 2020, Infectious Disease Clinics of North America.

Drug Resistance in Cryptococcus: Epidemiology and Molecular Mechanisms

J. Lodge, M. Ghannoum, M. Pfaller, 2011 .

Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.

M. Ghannoum, M. Robin, G. Socié, 2007, International journal of antimicrobial agents.

In Vitro Antifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries

M. Ghannoum, J. Guinea, P. Warn, 2009, Journal of chemotherapy.

Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.

M. Ghannoum, H. Sanati, N. Bhat, 1999, Journal of chemotherapy.

In Vitro Activities of Voriconazole, Fluconazole, and Itraconazole against 566 Clinical Isolates of Cryptococcus neoformans from the United States and Africa

M. Ghannoum, M. Brandt, M. Pfaller, 1999, Antimicrobial Agents and Chemotherapy.

Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.

M. Ghannoum, M. Pfaller, S. Messer, 1998, Diagnostic microbiology and infectious disease.

In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients.

M. Ghannoum, P. Mukherjee, R. Traboulsi, 2008, International journal of antimicrobial agents.

A Phase 2, Randomized, Double-Blind, Multicenter Trial To Evaluate the Safety and Efficacy of Three Dosing Regimens of Isavuconazole Compared with Fluconazole in Patients with Uncomplicated Esophageal Candidiasis

M. Ghannoum, A. Schmitt-Hoffmann, N. Azie, 2015, Antimicrobial Agents and Chemotherapy.

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

M. Ghannoum, J. Peter, T. Walsh, 2003, The Journal of infectious diseases.

Incidence and susceptibility of yeasts isolated from cancer patients in Kuwait.

M. Ghannoum, M. Motawy, H. Al-Awadhi, 2009, Mykosen.

Mechanism of Fluconazole Resistance inCandida krusei

M. Ghannoum, S. Filler, A. Ibrahim, 1998, Antimicrobial Agents and Chemotherapy.

Effects of antineoplastic agents on growth, morphology and metabolism of Torulopsis glabrata

M. Ghannoum, 1986, Mycopathologia.

Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria

M. Ghannoum, B. Griffiths, M. Bradley, 2003, International journal of dermatology.

Rhodococcus Bacteremia in Cancer Patients Is Mostly Catheter Related and Associated with Biofilm Formation

M. Ghannoum, J. Tarrand, I. Raad, 2012, PloS one.

Determination of MICs of Aminocandin for Candida spp. and Filamentous Fungi

M. Ghannoum, N. Isham, 2006, Journal of Clinical Microbiology.

Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism

M. Ghannoum, P. Mukherjee, J. Chandra, 2003, Journal of Clinical Microbiology.

The Gut Microbiome as a Major Regulator of the Gut-Skin Axis

M. Ghannoum, N. Isham, I. Salem, 2018, Front. Microbiol..

Combinations of antifungal and antineoplastic drugs with interactive effects on inhibition of yeast growth.

M. Ghannoum, R. Criddle, A. Ibrahim, 1990, Chemotherapy.

Effect of growth of Candida spp. in the presence of various glucocorticoids on the adherence to human buccal epithelial cells

M. Ghannoum, K. A. Elteen, 1987, Mycopathologia.

Growth of Candida albicans in dexamethasone-supplemented media.

M. Ghannoum, G. Burns, K. Abu Elteen, 1985, Sabouraudia.

Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis

M. Ghannoum, S. Lockhart, T. Walsh, 2011, Antimicrobial Agents and Chemotherapy.

Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage

A. Casadevall, M. Ghannoum, A. Ibrahim, 1995, Antimicrobial agents and chemotherapy.

Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole

A. Casadevall, M. Ghannoum, B. Spellberg, 1994, Antimicrobial Agents and Chemotherapy.

New Approaches to Candida and Oral Mycotic Infections

M. Ghannoum, L. Patton, P. Fidel, 2011, Advances in dental research.

Candida parapsilosis Characterization in an Outbreak Setting

M. Ghannoum, D. Soll, P. Mukherjee, 2004, Emerging infectious diseases.

Fungal biofilms and antimycotics.

M. Ghannoum, J. Chandra, Guangyin Zhou, 2005, Current drug targets.

Effects of voriconazole on Candida glabrata in vitro.

M. Ghannoum, J. Vitullo, A. Koul, 1999, The Journal of antimicrobial chemotherapy.

Repeated exposure of Candida spp. to miconazole demonstrates no development of resistance

M. Ghannoum, N. Isham, J. Herbert, 2011, Mycoses.

Overview of the Oral HIV/AIDS Research Alliance Program

M. Ghannoum, C. Shiboski, D. Dittmer, 2011, Advances in dental research.

Interaction of Candida albicans with Adherent Human Peripheral Blood Mononuclear Cells Increases C. albicans Biofilm Formation and Results in Differential Expression of Pro- and Anti-Inflammatory Cytokines

M. Ghannoum, P. Mukherjee, J. Chandra, 2007, Infection and Immunity.

Candida biofilm: a well-designed protected environment.

M. Ghannoum, P. Mukherjee, Ryan Munyon, 2005, Medical mycology.

Biofilm Antimicrobial Resistance

P. Stewart, M. Ghannoum, P. Mukherjee, 2004 .

Successful Treatment of Fluconazole-Resistant Oropharyngeal Candidiasis by a Combination of Fluconazole and Terbinafine

B. Elewski, M. Ghannoum, 1999, Clinical Diagnostic Laboratory Immunology.

Decreased fluconazole susceptibility of a relapse cryptococcus neoformans isolate after fluconazole treatment

A. Casadevall, M. Ghannoum, B. Currie, 1995 .

Interferon-gamma protects endothelial cells from damage by Candida albicans.

M. Ghannoum, S. Filler, A. Ibrahim, 1993, The Journal of infectious diseases.

A Head-on Comparison of the In Vitro Antifungal Activity of Conventional and Lipid-based Amphotericin B: a Multicenter Study

M. Ghannoum, M. Pfaller, S. Messer, 2000, Journal of chemotherapy.

Identification of gentian violet concentration that does not stain oral mucosa, possesses anti-candidal activity and is well tolerated

M. Ghannoum, R. Jurevic, P. Mukherjee, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

M. Ghannoum, P. Mukherjee, M. Retuerto, 2017, Antimicrobial Agents and Chemotherapy.

Antifungal Susceptibility Testing of Dermatophytes

M. Ghannoum, 2001 .

In Vitro Antifungal Activity of Naftifine Hydrochloride against Dermatophytes

M. Ghannoum, A. Verma, B. Hardas, 2013, Antimicrobial Agents and Chemotherapy.

Cloning and Characterization ofCAD1/AAF1, a Gene from Candida albicans That Induces Adherence to Endothelial Cells after Expression inSaccharomyces cerevisiae

M. Ghannoum, T. Kanbe, S. Filler, 1998, Infection and Immunity.

Determination of Minimum Inhibitory Concentration of Aminocandin against 1 Yeasts and Filamentous Fungi 2 3

M. Ghannoum, N. Isham, M. Ghannoum, 2022 .

Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Candida Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis

M. Ghannoum, S. Lockhart, M. Pfaller, 2022, Journal of fungi.

Silicon Phthalocyanine 4 Phototoxicity in Trichophyton rubrum

M. Ghannoum, P. Mukherjee, M. Retuerto, 2014, Antimicrobial Agents and Chemotherapy.

Incorporation of dexamethasone by Candida albicans.

M. Ghannoum, S. Mudher, G. Burns, 1985, Microbios.

Quality Control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against Molds

M. Ghannoum, W. Schell, T. Walsh, 2007, Journal of Clinical Microbiology.

An Unusual Periorbital Rash in a Child

M. Ghannoum, M. Jacobs, K. T. Yeo, 2012 .

Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis.

Pranab K Mukherjee, Mahmoud A Ghannoum, M. Ghannoum, 2010, International journal of medical microbiology : IJMM.

Effect of antineoplastic agents and X-irradiation on the adherence of Candida spp. to human buccal epithelial cells in vitro

M. Ghannoum, M. Motawy, K. Abu-Elteen, 1988, Mycopathologia.

Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro

M. Ghannoum, P. Dazin, A. Bayer, 1994, Antimicrobial Agents and Chemotherapy.

Erratum to: Amorolfine 5% Nail Lacquer Exhibits Potent Antifungal Activity Compared to Three Acid-Based Devices Indicated for the Treatment of Onychomycosis: An In Vitro Nail Penetration Assay

M. Ghannoum, M. Sarkany, K. Sevin, 2016, Dermatology and Therapy.

Antibacterial activity of some α- substituted 2-Methyl-5-nitrofurans

M. Ghannoum, W. Bowman, M. Thomson, 2008, Folia Microbiologica.

Effects of octenidine and pirtenidine on adhesion of Candida species to human buccal epithelial cells in vitro.

M. Ghannoum, P. Whittaker, R. Stretton, 1990, Archives of oral biology.

Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US.

B. Elewski, M. Ghannoum, C. R. Daniel, 2021, Journal of drugs in dermatology : JDD.

In Vitro Activity of Amphotericin B Against Aspergillus terreus Isolates from Different Countries and Regions

M. Ghannoum, D. Stevens, A. Tortorano, 2008, Journal of chemotherapy.

Effect of an Emollient on the Mycobiome of Atopic Dermatitis Patients.

M. Ghannoum, S. Seité, Richard Martin, 2018, Journal of drugs in dermatology : JDD.

Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action.

M. Ghannoum, 2015, Journal of the American Podiatric Medical Association.

Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species

M. Ghannoum, C. Donskey, J. Cadnum, 2017, Infection Control & Hospital Epidemiology.

Candida albicans and Candida krusei Differentially Induce Human Blood Mononuclear Cell Interleukin-12 and Gamma Interferon Production

M. Ghannoum, Y. Yoshida, Liming Liu, 2000, Infection and Immunity.

Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections

M. Ghannoum, A. Ibrahim, M. Hoenigl, 2022, Journal of fungi.

Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains

M. Ghannoum, M. Witt, E. Kim, 1996, Antimicrobial agents and chemotherapy.

Candida Adherence to Epithelial Cells

M. Ghannoum, S. Radwan, 2017 .

Efficacy of Care Solutions Against Contact Lens-Associated Fusarium Biofilms

M. Ghannoum, P. Mukherjee, M. Retuerto, 2012, Optometry and vision science : official publication of the American Academy of Optometry.

A murine model of contact lens-associated fusarium keratitis.

M. Ghannoum, P. Mukherjee, E. Pearlman, 2010, Investigative ophthalmology & visual science.

The Human Mycobiome and its Impact on Health and Disease

M. Ghannoum, P. Mukherjee, 2013, Current Fungal Infection Reports.

Growth of Candida albicans in the presence of hydrocarbons: a correlation between sterol concentration and hydrocarbon uptake

M. Ghannoum, S. Radwan, A. Ibrahim, 2004, Applied Microbiology and Biotechnology.

Multilaboratory Testing of Antifungal Combinations against a Quality Control Isolate of Candida krusei

M. Ghannoum, J. Rex, T. Walsh, 2008, Antimicrobial Agents and Chemotherapy.

Novel Antifungals for the Treatment of Vulvovaginal Candidiasis: Where Are We?

M. Ghannoum, A. Kadry, A. Gamal, 2022, Infectious Diseases.

Bacteriome and mycobiome associations in oral tongue cancer

B. Burkey, M. Ghannoum, C. Eng, 2017, Oncotarget.

Increased Resistance of Contact Lens-Related Bacterial Biofilms to Antimicrobial Activity of Soft Contact Lens Care Solutions

Pranab K Mukherjee, Mahmoud A Ghannoum, M. Ghannoum, 2009, Cornea.

Successful isavuconazole salvage therapy in a patient with invasive mucormycosis

M. Ghannoum, J. Ervens, B. Graf, 2014, Infection.

Occidiofungin, an actin binding antifungal with in vivo efficacy in a vulvovaginal candidiasis infection

S. W. Lockless, M. Ghannoum, Leif Smith, 2018, bioRxiv.

Nonspecific Effect of Mycograb on Amphotericin B MIC

M. Ghannoum, N. Ryder, N. Isham, 2012, Antimicrobial Agents and Chemotherapy.

Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model

M. Ghannoum, K. Borroto-Esoda, N. Isham, 2020, Antimicrobial Agents and Chemotherapy.

Proteomics and Pathway Mapping Analyses Reveal Phase-Dependent Over-Expression of Proteins Associated with Carbohydrate Metabolic Pathways in Candida albicans Biofilms

M. Ghannoum, M. Chance, P. Mukherjee, 2008 .

Temporal analysis of Candida albicans gene expression during biofilm development.

M. Ghannoum, K. Kwast, S. Rodriguez-Zas, 2007, Microbiology.

Diversity of Ocular Surface Bacterial Microbiome Adherent to Worn Contact Lenses and Bacterial Communities Associated With Care Solution Use.

M. Ghannoum, M. Cameron, P. Mukherjee, 2019, Eye & contact lens.

Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota

A. Grada, M. Ghannoum, S. Tyring, 2022, Antibiotics.

A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic

M. Ghannoum, R. Bonomo, T. McCormick, 2021, Frontiers in Nutrition.

Evaluation of Microbiome Alterations Following Consumption of BIOHM, a Novel Probiotic

M. Ghannoum, M. Retuerto, G. Bebek, 2021, Current issues in molecular biology.

Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans.

M. Ghannoum, S. Nakashima, Y. Banno, 1995, Biochimica et biophysica acta.

Therapeutic Challenges of Aids-related Non-hodgkin's Lymphoma in the United States and East Africa

John L. Johnson, M. Lederman, M. Ghannoum, 2022 .

Endothelial Cell Injury Caused by Candida albicans Is Dependent on Iron

M. Ghannoum, S. Filler, J. Edwards, 1998, Infection and Immunity.

Iron deprivation induces EFG1-mediated hyphal development in Candida albicans without affecting biofilm formation.

Dibyendu Banerjee, Pranab K Mukherjee, Mahmoud A Ghannoum, 2008, FEMS yeast research.

Candida albicans RHO1 is required for cell viability in vitro and in vivo.

M. Ghannoum, G. Reyes, Susan E. Smith, 2002, FEMS yeast research.

Capacity building for the clinical investigation of AIDS malignancy in East Africa.

John L. Johnson, M. Lederman, M. Ghannoum, 2005, Cancer detection and prevention.

A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vivo Activity in a Murine Model of Hematogenously Disseminated Candida albicans

M. Ghannoum, K. Borroto-Esoda, T. McCormick, 2020, Antimicrobial Agents and Chemotherapy.

Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species

M. Ghannoum, D. Perlin, G. Garcia-Effron, 2010, Antimicrobial Agents and Chemotherapy.

Cloning and characterization of CAD1/AAF1, a gene from Candida albicans that induces adherence to endothelial cells after expression in Saccharomyces cerevisiae.

M. Ghannoum, T. Kanbe, S. Filler, 1998, Infection and immunity.

Alterations in the oral microbiome in HIV-infected participants after ART administration are influenced by immune status.

M. Ghannoum, C. Shiboski, M. Jacobson, 2018, AIDS.

Gastrointestinal Microbiome and Mycobiome Changes during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study.

M. Ghannoum, R. Sékaly, M. Retuerto, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Microbiome: Its Impact Is Being Revealed!

M. Ghannoum, H. Lazarus, N. El-Jurdi, 2017, Current Clinical Microbiology Reports.

Cooperative Evolutionary Strategy between the Bacteriome and Mycobiome

M. Ghannoum, 2016, mBio.

Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia

M. Ghannoum, T. McCormick, K. Cooper, 2005, Contact dermatitis.

Do Antifungals and Local Anesthetic Affect the Efficacy of Antibiotic Dipping Solution?

M. Ghannoum, Kirtishri Mishra, L. Long, 2021, The journal of sexual medicine.

Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans.

Rupinder Kaur, Pranab K Mukherjee, Neeraj Chauhan, 2014, The Biochemical journal.

BIOHM Probiotics Retain Viability in Low pH Environments Simulating the Digestive Environment

M. Ghannoum, N. Isham, L. Long, 2019, Journal of Probiotics & Health.

Intestinal Stem Cell Niche Defects Result in Impaired 3D Organoid Formation in Mouse Models of Crohn's Disease-like Ileitis

M. Ghannoum, M. Dave, R. Sékaly, 2020, Stem cell reports.

Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV.

M. Ghannoum, M. Retuerto, Vanessa El Kamari, 2019, AIDS research and human retroviruses.

Differential expression of Candida albicans phospholipase B (PLB1) under various environmental and physiological conditions.

M. Ghannoum, P. Mukherjee, J. Chandra, 2003, Microbiology.

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens

M. Ghannoum, M. Shoham, W. Harte, 2018, Scientific Reports.

Influence of gut microbiome on multiple myeloma: friend or foe?

M. Ghannoum, M. Gallogly, M. de Lima, 2020, Journal for immunotherapy of cancer.

M. Ghannoum, M. Schinabeck, 2005 .

The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis

M. Ghannoum, M. Retuerto, S. Durum, 2018, Inflammatory bowel diseases.

The mycobiome in HIV

M. Ghannoum, C. Hager, 2018, Current opinion in HIV and AIDS.

Novel Quorum-Quenching Agents Promote Methicillin-Resistant Staphylococcus aureus (MRSA) Wound Healing and Sensitize MRSA to β-Lactam Antibiotics

M. Ghannoum, M. Shoham, C. Harding, 2014, Antimicrobial Agents and Chemotherapy.

Multilaboratory Testing of Antifungal Drug Combinations against Candida Species and Aspergillus fumigatus: Utility of 100 Percent Inhibition as the Endpoint

M. Ghannoum, S. Lockhart, M. Pfaller, 2014, Antimicrobial Agents and Chemotherapy.

The Mycobiome: Impact on Health and Disease States.

M. Ghannoum, N. El-Jurdi, 2017, Microbiology spectrum.

Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection

M. Ghannoum, P. Mukherjee, M. Retuerto, 2018, PloS one.

Effect of Mycobiome Diet on Gut Fungal and Bacterial Communities of Healthy Adults

M. Ghannoum, M. Retuerto, A. E., 2020 .

Multilaboratory Testing of Antifungal Drug Combinations against Candida species and Aspergillus 1

M. Ghannoum, S. Lockhart, D. Diekema, 2014 .

Characterization of Bacterial Communities in Venous Insufficiency Wounds by Use of Conventional Culture and Molecular Diagnostic Methods

M. Ghannoum, S. Dowd, P. Mukherjee, 2011, Journal of Clinical Microbiology.

The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.

M. Ghannoum, I. Raad, R. Hachem, 2011, Biomaterials.

M. Ghannoum, M. Schinabeck, 2003 .

N-Acetylcysteine Lock Solution Prevents Catheter-Associated Bacteremia in Rabbits

M. Ghannoum, R. Mehta, S. Reed, 2012, The International journal of artificial organs.

Antimicrobial Activity of B-Lock against Bacterial and Candida spp. Causing Catheter-Related Bloodstream Infections

M. Ghannoum, M. Jacobs, N. Isham, 2011, Antimicrobial Agents and Chemotherapy.

Molecular Diagnosis of SARS-CoV-2: Assessing and Interpreting Nucleic Acid and Antigen Tests

M. Ghannoum, R. Bonomo, C. King, 2021, Pathogens & immunity.

Diagnostic Methods Conventional Culture and Molecular in Venous Insufficiency Wounds by Use of Characterization of Bacterial Communities

M. Ghannoum, S. Dowd, P. Mukherjee, 2012 .

Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.

M. Ghannoum, P. Mukherjee, M. Retuerto, 2013, Omics : a journal of integrative biology.

Effect of Parenteral Antibiotic Administration on Establishment of Intestinal Colonization by Candida glabrata in Adult Mice

M. Ghannoum, C. Donskey, M. S. Helfand, 2005, Antimicrobial Agents and Chemotherapy.

Modulating the Microbiome for Disease Treatment.

M. Ghannoum, T. McCormick, L. Di Martino, 2023, Gastroenterology.

Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections

M. Ghannoum, P. Mukherjee, R. Salata, 2017, BMC Infectious Diseases.

A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis

M. Ghannoum, K. Borroto-Esoda, N. Isham, 2019, Antimicrobial Agents and Chemotherapy.

Photodynamic Therapy with Pc 4 Induces Apoptosis of Candida albicans

M. Ghannoum, N. Oleinick, P. Mukherjee, 2011, Photochemistry and photobiology.

Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi

M. Ghannoum, J. Turnidge, W. Schell, 2011, Journal of Clinical Microbiology.

Shear stress modulates the thickness and architecture of Candida albicans biofilms in a phase‐dependent manner

M. Ghannoum, P. Mukherjee, J. Chandra, 2009, Mycoses.

Admission to the Intensive Care Unit is Associated With Changes in the Oral Mycobiome

M. Ghannoum, P. Mukherjee, M. Retuerto, 2017, Journal of intensive care medicine.

The Fungal Biome of the Oral Cavity.

M. Ghannoum, P. Mukherjee, M. Retuerto, 2016, Methods in molecular biology.

Assessing the Severity and Impact of Oral Mucositis after Autologous Transplantation for Myeloma: A Prospective Pilot Study Comparing the Patient-Reported Quality of Life and Objective Evaluation by a Healthcare Professional

M. Ghannoum, N. Dambrosio, R. Mendes, 2018 .

Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis

M. Ghannoum, T. McCormick, J. Aram, 2021, Antimicrobial agents and chemotherapy.

In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris

M. Ghannoum, T. McCormick, L. Long, 2021, Antimicrobial Agents and Chemotherapy.

Breakthrough fungal infections after allogeneic hematopoietic cell transplant: Improved understanding and new strategic approach with sargramostim.

M. Ghannoum, H. Lazarus, T. McCormick, 2021, Clinical immunology.

SCY-078, a Novel Oral Glucan Synthase Inhibitor, for the Treatment of Invasive Aspergillosis: Evaluation of Antifungal Activity Singly and in Combination

M. Ghannoum, K. Borroto-Esoda, N. Isham, 2018 .

Inhibition of Candida adhesion to buccal epithelial cells by an aqueous extract of Allium sativum (garlic).

M. Ghannoum, 1990, The Journal of applied bacteriology.

Chromatographic Analysis of Lipids

M. Ghannoum, Ashraf S. Ibrahim, 1996 .

Fungal Biofilms: Agents of Disease and Drug Resistance

M. Ghannoum, J. Lopez-Ribot, G. Ramage, 2006 .

Antifungal Therapy

J. Perfect, M. Ghannoum, 2019, Mader's Reptile and Amphibian Medicine and Surgery.

SCY-078, a Novel Oral Glucan Synthase Inhibitor, for the Treatment of Invasive Aspergillosis: Evaluation of Antifungal Activity Singly and in Combination

M. Ghannoum, K. Borroto-Esoda, N. Isham, 2018 .

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

M. Ghannoum, P. Mukherjee, D. Andes, 2018, Antimicrobial Agents and Chemotherapy.

Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients.

M. Ghannoum, T. McCormick, B. Carroll, 2023, Archives of dermatological research.

Transplant Outcomes and Toxicities Are Associated with Changes in Relative Abundance, Diversity and Richness of the Oral and Gastrointestinal Microbiome during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study

M. Ghannoum, R. Sékaly, M. Retuerto, 2019, Biology of Blood and Marrow Transplantation.

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

P. Nyirjesy, M. Ghannoum, R. Sobel, 2021, BJOG : an international journal of obstetrics and gynaecology.

The Oral HIV/AIDS Research Alliance Program: lessons learned and future directions.

M. Ghannoum, C. Shiboski, D. Dittmer, 2016, Oral diseases.

Shear stress modulates the thickness and architecture of Candida albicans biofilms in a phase‐dependent manner

M. Ghannoum, P. Mukherjee, J. Chandra, 2009, Mycoses.

Mycobiota in gastrointestinal diseases

M. Ghannoum, P. Mukherjee, J. Colombel, 2015, Nature Reviews Gastroenterology &Hepatology.

CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms

M. Ghannoum, J. Chandra, 2017, Antimicrobial Agents and Chemotherapy.

Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species

M. Ghannoum, D. Perlin, H. Bonilla, 2010, Antimicrobial Agents and Chemotherapy.

Sterols and diacylglycerophosphocholines in the lipids of the hydrocarbon-utilizing prokaryote Rhodococcus rhodochrous

M. Ghannoum, S. Radwan, A. Ibrahim, 1990 .

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

J. S. Daly, A. Casadevall, I. Sia, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A second look at efficacy criteria for onychomycosis: clinical and mycological cure

M. Ghannoum, N. Isham, V. Catalano, 2014, The British journal of dermatology.

International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method

M. Ghannoum, T. Peláez, M. Pfaller, 2015, Antimicrobial Agents and Chemotherapy.

Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.

John L. Johnson, M. Lederman, M. Ghannoum, 2002, Journal of the National Cancer Institute.

INTRODUCTION TO BIOFILMS: CONCEPTUAL THEMES

George A. O'Toole, Mahmoud A. Ghannoum, M. Ghannoum, 2004 .

Growth and Lipid Composition of Some Dematiaceous Hyphomycete Fungi Grown at Different Salinities

M. Ghannoum, J. Mulder, L. Khamis, 1989 .

Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation.

M. Ghannoum, P. Mukherjee, R. Welti, 2011, Microbiology.

Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action.

M. Ghannoum, 2015, Journal of the American Podiatric Medical Association.

Photodynamic Therapy with Pc 4 Induces Apoptosis of Candida albicans

M. Ghannoum, N. Oleinick, P. Mukherjee, 2011, Photochemistry and photobiology.